Summary
We have shown previously that the relative expression of a truncated oestrogen receptor-α variant mRNA (ER clone 4) is significantly increased in axillary node-positive primary breast tumours compared with node-negative tumours. In this study, we have examined the relative expression of clone 4-truncated, exon 5-deleted and exon 7-deleted oestrogen receptor-α variant mRNAs in 15 primary breast tumour samples and in synchronous axillary lymph node metastases. Overall, there were no significant differences between the primary tumours and the matched metastases in the relative expression of these three specific variant mRNAs. Furthermore, the pattern of all deleted oestrogen receptor-α variant mRNAs appeared conserved between any primary and its matched secondary tumour.
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Daffada, A. A., Johnston, S. R., Nicholls, J. & Dowsett, M. (1994). Detection of wild type and exon 5-deleted splice variant oestrogen receptor (ER) mRNA in ER-positive and -negative breast cancer cell lines by reverse transcription/polymerase chain reaction. J Mol Endocrinol 13: 265–273.
Daffada, A. A., Johnston, S. R., Smith, I. E., Detre, S., King, N. & Dowsett, M. (1995). Exon 5 deletion variant estrogen receptor messenger RNA expression in relation to tamoxifen resistance and progesterone receptor/pS2 status in human breast cancer. Cancer Res 55: 288–293.
Desai, A., Luqmani, Y., Coope, R., Dagg, B., Gomm, J., Pace, P., Rees, C., Thirunavukkarasu, V., Shousha, S., Groome, N., Coombes, R. & Ali, S. (1997). Presence of exon 5 deleted oestrogen receptor in human breast cancer: functional analysis and clinical significance. Br J Cancer 75: 1173–1184.
Dotzlaw, H., Miller, T., Karvelas, J. & Murphy, L. C. (1990). Epidermal growth factor gene expression in human breast cancer biopsy samples: relationship to estrogen and progesterone receptor gene expression. Cancer Res 50: 4204–4208.
Dotzlaw, H., Alkhalaf, M. & Murphy, L. C. (1992). Characterization of estrogen receptor variant mRNAs from human breast cancers. Mol Endocrinol 6: 773–785.
Dowsett, M., Daffada, A., Chan, C. & Johnston, S. (1997). Oestrogen receptor mutants and variants in breast cancer. Eur J Cancer 33: 1177–1183.
Fasco, M. (1997). Quantitation of estrogen receptor mRNA and its alternatively spliced mRNAs in breast tumor cells and tissues. Anal Biochem 245: 167–178.
Green, S., Walter, P., Kumar, V., Krust, A., Bornert, J., Argos, P. & Chambon, P. (1986). Human estrogen receptor cDNA: sequence, expression, and homology to v-erb-A. Nature 320: 134–139.
Hahnel, R. & Twaddle, E. (1985). The relationship between estrogen receptors in primary and secondary breast carcinomas and in sequential primary breast carcinomas. Breast Cancer Res Treat 5: 155–163.
Huang, A., Leygue, E., Snell, L., Murphy, L. C. & Watson, P. (1997). Expression of estrogen receptor variants mRNAs and determination of estrogen status in human breast cancer. Am J Pathol 150: 1827–1833.
Khan, S. A., Rogers, M. A., Obando, J. A. & Tamsen, A. (1994). Estrogen receptor expression of benign breast epithelium and its association with breast cancer. Cancer Res 54: 993–997.
Leygue, E. R., Watson, P. H. & Murphy, L. C. (1996a). Estrogen receptor variants in normal human mammary tissue. J Natl Cancer Inst 88: 284–290.
Leygue, E., Murphy, L. C., Kuttenn, F. & Watson, P. (1996b). Triple primer polymerase chain reaction. A new way to quantify truncated mRNA expression. Am J Pathol 148: 1097–1103.
Leygue, E., Huang, A., Murphy, L. C. & Watson, P. (1996c). Prevalence of estrogen receptor variant messenger RNAs in human breast cancer. Cancer Res 56: 4324–4327.
Murphy, L. C. & Dotzlaw, H. (1989). Variant estrogen receptor mRNA species detected in human breast cancer biopsy samples. Mol Endocrinol 3: 687–693.
Murphy, L. C., Hilsenbeck, S. G., Dotzlaw, H. & Fuqua, S. A. W. (1995). Relationship of clone 4 estrogen receptor variant messenger RNA expression to some known prognostic variables in human breast cancer. Clin Cancer Res 1: 155–159.
Murphy, L. C., Dotzlaw, H., Leygue, E., Douglas, D., Coutts, A. & Watson, P. (1997a). Estrogen receptor variants and mutations: a review. J Steroid Biochem Mol Biol 62: 363–372.
Murphy, L. C., Leygue, E., Dotzlaw, H., Douglas, D., Coutts, A. & Watson, P. (1997b). Oestrogen receptor variants and mutations in human breast cancer. Ann Med 29: 221–234.
Park, W., Choi, J., Hwang, E. & Lee, J. (1996). Identification of a variant estrogen receptor lacking exon 4 and its coexpression with wild type estrogen receptor in ovarian carcinomas. Clin Cancer Res 2: 2029–2035.
Robertson, J. (1996). Oestrogen receptor: a stable phenotype in breast cancer. Br J Cancer 73: 5–12.
Schmitt, F. (1995). Multistep progression from an oestrogen dependent growth towards an autonomous growth in breast carcinogenesis. Eur J Cancer 12: 2049–2052.
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Leygue, E., Hall, R., Dotzlaw, H. et al. Oestrogen receptor-α variant mRNA expression in primary human breast tumours and matched lymph node metastases. Br J Cancer 79, 978–983 (1999). https://doi.org/10.1038/sj.bjc.6690156
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1038/sj.bjc.6690156
